GALLO, PAOLO
 Distribuzione geografica
Continente #
EU - Europa 64
NA - Nord America 55
AS - Asia 17
OC - Oceania 4
SA - Sud America 4
AF - Africa 1
Totale 145
Nazione #
US - Stati Uniti d'America 46
GB - Regno Unito 23
IT - Italia 13
DE - Germania 11
CA - Canada 9
FR - Francia 7
TR - Turchia 5
AU - Australia 4
HK - Hong Kong 3
NL - Olanda 2
PL - Polonia 2
UA - Ucraina 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AZ - Azerbaigian 1
BR - Brasile 1
CH - Svizzera 1
CL - Cile 1
CY - Cipro 1
ES - Italia 1
ET - Etiopia 1
FI - Finlandia 1
HU - Ungheria 1
ID - Indonesia 1
IN - India 1
JP - Giappone 1
KZ - Kazakistan 1
PE - Perù 1
SA - Arabia Saudita 1
SG - Singapore 1
Totale 145
Città #
London 20
Council Bluffs 8
San Francisco 8
Toronto 7
Ashburn 5
New York 4
Rome 4
Seelze 4
Brownsville 3
Canberra 3
Paris 3
Boardman 2
Caldogno 2
Hanover 2
Kharkiv 2
Los Angeles 2
Perugia 2
Warsaw 2
Amsterdam 1
Budapest 1
Central 1
Chantilly 1
Cleveland 1
Cold Lake 1
Foligno 1
Frankfurt am Main 1
Helsinki 1
Houston 1
Lima 1
L’Aquila 1
Melbourne 1
Mirabella Eclano 1
Newark 1
Nicosia 1
Redmond 1
Riyadh 1
Secaucus 1
Singapore 1
Stoney Creek 1
Stow 1
São Paulo 1
Totale 106
Nome #
Prognostication in NAFLD: physiological bases, clinical indicators, and newer biomarkers 8
Prediction of type 4a myocardial infarction with the angiography-derived hemodynamic (ADDED) index 7
Prognostic relevance of glomerular filtration rate estimation obtained through different equations in hospitalized elderly patients 7
Angiogenic cytokines in patients undergoing antiviral treatment for chronic hepatitis C virus infection 6
Reply to the Letter: “Low levels of transaminase and mortality risk in older people with special reference to sarcopenia” 6
Usefulness of Adding Pre-procedural Glycemia to the Mehran Score to Enhance Its Ability to Predict Contrast-induced Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention Development and Validation of a Predictive Model 5
Drug-drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients 5
Determinants of alanine aminotransferase levels in a large population from Southern Italy: relationship between alanine aminotransferase and age 5
Combined evaluation of aminotransferases improves risk stratification for overall and cause-specific mortality in older patients 5
Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register 5
Thrombocytopenia in chronic liver disease: Physiopathology and new therapeutic strategies before invasive procedures 4
Current Treatment Options for HCC: From Pharmacokinetics to Efficacy and Adverse Events in Liver Cirrhosis 4
BREATH PRINT ANALYSIS BY E-NOSE IS ASSOCIATED WITH ADVERSE OUTCOMES OF CIRRHOTIC PATIENTS INDEPENDENTLY FROM THE OTHER PROGNOSTIC INDICES 4
The hepatic expression of lysosomal acid lipase (LAL) is reduced in NAFLD patients, and associated with features of genetically determined LAL deficiency and NAFLD activity score 4
A case of Henoch-Schönlein purpura in the elderly: not just a 'second childhood' 4
Relationship Between the Completeness of Revascularization and Myocardial Injury in Patients Treated With Percutaneous Coronary Intervention 3
Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens 3
A challenging alfa-fetoprotein in a cirrhotic patient 3
The role of intestinal microbiota in the pathogenesis of NAFLD: starting points for intervention 3
Hepatocellular carcinoma in alcoholic liver disease: current management and recent advances 3
Haemorrhoidal disease in severe portal hypertension: a combined approach with transjugular intrahepatic portosystemic shunt (TIPS) and transanal haemorrhoidal dearterialization (THD) 3
Breath-print analysis by e-nose may refine risk stratification for adverse outcomes in cirrhotic patients 3
LIVER TOXICITY IN COLORECTAL CANCER PATIENTS TREATED WITH FIRST LINE FOLFIRI-CONTAINING REGIMEN: A SINGLE INSTITUTION EXPERIENCE 3
Assessment of liver function by the exhaled breath-print during chronic liver disease 3
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 3
Hepatitis A virus in a medical setting in Madagascar: a lesson for public health 3
In situ electrostimulation drives a regenerative shift in the zone of infarcted myocardium 3
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) 3
What changed in the Italian internal medicine and geriatric wards during the lockdown 3
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 3
The Italian multiple sclerosis register 3
Glycaemic Control in Patients Undergoing Percutaneous Coronary Intervention: What Is the Role for the Novel Antidiabetic Agents? A Comprehensive Review of Basic Science and Clinical Data 3
Beyond the Calcium Score: What Additional Information from a CT Scan Can Assist in Cardiovascular Risk Assessment? 2
Hepatic complications of bariatric surgery : the reverse side of the coin 2
Potentially inappropriate medications, drug–drug interactions, and anticholinergic burden in elderly hospitalized patients: does an association exist with post-discharge health outcomes? 2
Diagnostic value of Virtual Touch Quantification (VTQ®) for differentiation of hemangiomas from malignant focal liver lesions 2
THU-390 - Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 2
Coexistence of HBsAg and HBsAb in a difficult-to-treat chronic hepatitis B: loss of HBsAg with entecavir plus tenofovir combination 2
Lysosomal acid lipase activity is reduced both in cryptogenic cirrhosis and in cirrhosis of known etiology 2
Combining genetic variants to improve risk prediction for nafld and its progression to cirrhosis: a proof of concept study 2
Breath-print analysis by e-nose for classifying and monitoring chronic liver disease: a proof-of-concept study 2
Impairment of GH/IGF-1 Axis in the liver of patients with hcv-related chronic hepatitis 2
Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 2
Deep vein thrombosis, inferior vena cava interruption and multiple thrombophilic gene mutations 2
Hepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis 2
Pain and Frailty in Hospitalized Older Adults 2
Impact of oral anticoagulant regimens on occurrence of contrast-induced nephropathy in patients undergoing coronary angioplasty 2
Renal impairment and anemia during triple therapy 1
Promoting genetics in non-alcoholic fatty liver disease: Combined risk score through polymorphisms and clinical variables 1
Non-cirrhotic portal hypertension with large regenerative nodules: a diagnostic challenge 1
Telaprevir raises the plasma/whole blood ribavirin ratio: trying to come full circle on a dangerous relationship 1
Platelet count may impact on lysosomal acid lipase activity determination in dried blood spot 1
Liver toxicity in colorectal cancer patients treated with first-line FOLFIRI-containing regimen: a single institution experience 1
Totale 166
Categoria #
all - tutte 6.137
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.137


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022102 0 1 4 0 1 0 0 2 14 0 0 80
2022/202334 2 0 3 3 3 2 4 0 1 5 11 0
2023/202430 11 15 4 0 0 0 0 0 0 0 0 0
Totale 166